Related Experiment Video
Updated: Mar 25, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Lung Function Impairment and Its Associated Factors in Pulmonary Tuberculosis Patients Upon Treatment Completion in
Pooranagangadevi Navaneethapandian1, Prabhakaran S Sarma1, Mahalakshmi Rajendran2
1Public Health, Amrita Institute of Medical Sciences, Kochi, IND.
Abstract:
Background While effective anti-tuberculosis treatment (ATT) has led to significant reductions in mortality, concerns persist about the potential for persistent lung damage and impaired pulmonary function among survivors. Data on the prevalence and predictors of lung function impairment (LFI) in post-TB patients in Tamil Nadu are limited. This study aims to evaluate the extent of LFI in pulmonary tuberculosis (PTB) patients upon treatment completion. Methods A cross-sectional analytical study was conducted among 132 adult patients aged 18 years and above diagnosed with PTB registered in the government National TB Elimination Program (NTEP) centres, in Madurai district, Tamil Nadu, with smear negative status at completion of standard ATT. Information was obtained on personal habits, respiratory symptoms and co-morbid conditions. A pulmonary function test was done using spirometry. Multiple binary logistic regression analysis was done to find the factors associated with LFI. Results Among the patients, 78 (59%; 95% CI (51% to 67%)) showed LFI. The most common abnormality identified was the restrictive pattern, seen in 72 individuals (55%). Patients with a previous history of anti-tuberculosis treatment (adjusted odds ratio (AOR) 2.4; 95% CI 1.0-5.7; p =0.034)), bilateral lung infiltrates (AOR 7.9; 95% CI: 2.7-23.3; p < 0.001), and ≥4 chest X-ray zones (AOR 11.1 CI 2.9-42.3; p <0.001) were more likely to have LFI. Conclusion LFI is highly prevalent among PTB patients after treatment completion, with previous TB episodes, radiological severity, and bilateral infiltrates being strong predictors. These findings underscore the necessity of post-treatment pulmonary surveillance, spirometry, and pulmonary rehabilitation to be integrated into TB care frameworks in this population.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:42Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Other Pulmonary Disorders